UY39066A - Moduladores de monoacilglicerol lipasa - Google Patents
Moduladores de monoacilglicerol lipasaInfo
- Publication number
- UY39066A UY39066A UY0001039066A UY39066A UY39066A UY 39066 A UY39066 A UY 39066A UY 0001039066 A UY0001039066 A UY 0001039066A UY 39066 A UY39066 A UY 39066A UY 39066 A UY39066 A UY 39066A
- Authority
- UY
- Uruguay
- Prior art keywords
- methods
- disorders
- monacilglycerol
- lipase
- modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062972484P | 2020-02-10 | 2020-02-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY39066A true UY39066A (es) | 2021-08-31 |
Family
ID=74595268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001039066A UY39066A (es) | 2020-02-10 | 2021-02-09 | Moduladores de monoacilglicerol lipasa |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US11708359B2 (ja) |
| EP (1) | EP4103557A1 (ja) |
| JP (1) | JP2023512729A (ja) |
| KR (1) | KR20220140581A (ja) |
| CN (1) | CN115066422A (ja) |
| AR (1) | AR121296A1 (ja) |
| AU (1) | AU2021220539A1 (ja) |
| BR (1) | BR112022015116A2 (ja) |
| CA (1) | CA3169988A1 (ja) |
| CL (1) | CL2022002136A1 (ja) |
| CO (1) | CO2022011275A2 (ja) |
| CR (1) | CR20220376A (ja) |
| DO (1) | DOP2022000162A (ja) |
| EC (1) | ECSP22062460A (ja) |
| IL (1) | IL295447A (ja) |
| JO (1) | JOP20220180A1 (ja) |
| MX (1) | MX2022009804A (ja) |
| PE (1) | PE20221576A1 (ja) |
| TW (1) | TW202140465A (ja) |
| UY (1) | UY39066A (ja) |
| WO (1) | WO2021160602A1 (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022009804A (es) | 2020-02-10 | 2022-09-02 | Janssen Pharmaceutica Nv | Moduladores de la monoacilglicerol lipasa. |
| AU2021240349A1 (en) | 2020-03-26 | 2022-09-29 | Janssen Pharmaceutica Nv | Aminocyclobutanes as monoacylglycerol lipase modulators |
| US11505546B2 (en) | 2020-03-26 | 2022-11-22 | Janssen Pharmaceutica Nv | Azaspirocycles as monoacylglycerol lipase modulators |
| AU2021243726A1 (en) | 2020-03-26 | 2022-09-29 | Janssen Pharmaceutica Nv | Aryl piperidines as monoacylglycerol lipase modulators |
| US12115154B2 (en) | 2020-12-16 | 2024-10-15 | Srx Cardio, Llc | Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) |
| CA3228446A1 (en) | 2021-08-09 | 2023-02-16 | Janssen Pharmaceutica Nv | Monoacylglycerol lipase modulators for use in autism spectrum disorders |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060135508A1 (en) | 2002-07-25 | 2006-06-22 | Manuela Villa | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| EP2090576A1 (en) | 2008-02-01 | 2009-08-19 | Merz Pharma GmbH & Co.KGaA | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators |
| JP2014528428A (ja) * | 2011-09-30 | 2014-10-27 | ヤンセン ファーマシューティカ エヌ．ベー． | 代謝症及び関連障害の治療のためのモノアシルグリセロールリパーゼ阻害剤 |
| JP6832342B2 (ja) | 2016-03-31 | 2021-02-24 | 武田薬品工業株式会社 | 複素環化合物 |
| DK3436444T3 (da) * | 2016-03-31 | 2020-07-27 | Takeda Pharmaceuticals Co | Heterocyklisk forbindelse |
| BR112020005720A2 (pt) * | 2017-09-29 | 2020-10-20 | Takeda Pharmaceutical Company Limited | composto ou sal, medicamento, métodos para inibir monoacilglicerol lipase e para a profilaxia ou o tratamento de doença de alzheimer, doença de parkinson, doença de huntington, esclerose lateral amiotrófica, esclerose múltipla, distúrbio de ansiedade, dor, epilepsia ou depressão, e, uso do composto ou sal. |
| WO2020211798A1 (zh) | 2019-04-16 | 2020-10-22 | 上海翰森生物医药科技有限公司 | 含二并环类衍生物抑制剂、其制备方法和应用 |
| MX2022009804A (es) | 2020-02-10 | 2022-09-02 | Janssen Pharmaceutica Nv | Moduladores de la monoacilglicerol lipasa. |
| AU2021240349A1 (en) | 2020-03-26 | 2022-09-29 | Janssen Pharmaceutica Nv | Aminocyclobutanes as monoacylglycerol lipase modulators |
| US11505546B2 (en) | 2020-03-26 | 2022-11-22 | Janssen Pharmaceutica Nv | Azaspirocycles as monoacylglycerol lipase modulators |
| AU2021243726A1 (en) | 2020-03-26 | 2022-09-29 | Janssen Pharmaceutica Nv | Aryl piperidines as monoacylglycerol lipase modulators |
-
2021
- 2021-02-09 MX MX2022009804A patent/MX2022009804A/es unknown
- 2021-02-09 WO PCT/EP2021/053062 patent/WO2021160602A1/en active Application Filing
- 2021-02-09 TW TW110104960A patent/TW202140465A/zh unknown
- 2021-02-09 CR CR20220376A patent/CR20220376A/es unknown
- 2021-02-09 CN CN202180013762.3A patent/CN115066422A/zh active Pending
- 2021-02-09 JO JOP/2022/0180A patent/JOP20220180A1/ar unknown
- 2021-02-09 PE PE2022001698A patent/PE20221576A1/es unknown
- 2021-02-09 CA CA3169988A patent/CA3169988A1/en active Pending
- 2021-02-09 AU AU2021220539A patent/AU2021220539A1/en active Pending
- 2021-02-09 AR ARP210100333A patent/AR121296A1/es unknown
- 2021-02-09 UY UY0001039066A patent/UY39066A/es unknown
- 2021-02-09 KR KR1020227031216A patent/KR20220140581A/ko unknown
- 2021-02-09 BR BR112022015116A patent/BR112022015116A2/pt unknown
- 2021-02-09 IL IL295447A patent/IL295447A/en unknown
- 2021-02-09 US US17/171,559 patent/US11708359B2/en active Active
- 2021-02-09 EP EP21705124.2A patent/EP4103557A1/en active Pending
- 2021-02-09 JP JP2022548400A patent/JP2023512729A/ja active Pending
-
2022
- 2022-08-08 CL CL2022002136A patent/CL2022002136A1/es unknown
- 2022-08-09 EC ECSENADI202262460A patent/ECSP22062460A/es unknown
- 2022-08-10 CO CONC2022/0011275A patent/CO2022011275A2/es unknown
- 2022-08-10 DO DO2022000162A patent/DOP2022000162A/es unknown
-
2023
- 2023-06-02 US US18/328,242 patent/US20230382902A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021160602A1 (en) | 2021-08-19 |
| JOP20220180A1 (ar) | 2023-01-30 |
| JP2023512729A (ja) | 2023-03-28 |
| EP4103557A1 (en) | 2022-12-21 |
| ECSP22062460A (es) | 2022-11-30 |
| US11708359B2 (en) | 2023-07-25 |
| TW202140465A (zh) | 2021-11-01 |
| AU2021220539A1 (en) | 2022-10-06 |
| US20210253565A1 (en) | 2021-08-19 |
| MX2022009804A (es) | 2022-09-02 |
| AR121296A1 (es) | 2022-05-04 |
| IL295447A (en) | 2022-10-01 |
| CL2022002136A1 (es) | 2023-02-03 |
| CN115066422A (zh) | 2022-09-16 |
| PE20221576A1 (es) | 2022-10-06 |
| US20230382902A1 (en) | 2023-11-30 |
| DOP2022000162A (es) | 2022-10-31 |
| KR20220140581A (ko) | 2022-10-18 |
| CR20220376A (es) | 2022-09-16 |
| CA3169988A1 (en) | 2021-08-19 |
| BR112022015116A2 (pt) | 2022-09-27 |
| CO2022011275A2 (es) | 2022-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY39066A (es) | Moduladores de monoacilglicerol lipasa | |
| NI202100023A (es) | Moduladores de monoacilglicerol lipasa | |
| MX2021003661A (es) | Moduladores de la monoacilglicerol lipasa. | |
| BR112022019155A2 (pt) | Aril piperidinas como moduladores da monoacilglicerol lipase | |
| BR112022019211A2 (pt) | Azaspirociclos como moduladores de lipase de monoacilglicerol | |
| MX2022011904A (es) | Aminociclobutanos como moduladores de monoacilglicerol lipasa. | |
| BR112022019077A2 (pt) | Moduladores da monoacilglicerol lipase | |
| CL2023001195A1 (es) | Compuestos bicíclicos y usos de los mismos para el tratamiento de enfermedades. | |
| CO2024002075A2 (es) | Compuestos n-acilhidrazónicos inhibidores de nav 1.7 y/o nav 1.8, sus procesos de obtención, composiciones, usos, métodos de tratamiento de estos y kits | |
| UY38304A (es) | Dinucleótidos cíclicos como agonistas de sting y composiciones farmacéuticas que los contienen | |
| CO2023000016A2 (es) | Proteínas enpp1 o enpp3 solubles y sus usos | |
| DOP2022000127A (es) | Triterpenoides sintéticos con sustituyentes a base de nitrógeno en c-17 y métodos de uso de los mismos. | |
| CL2022000147A1 (es) | Derivados de piridina como moduladores de tmem16a para su uso en el tratamiento de afecciones respiratorias. | |
| AR123154A1 (es) | Derivados heterocíclicos sustituidos de pirazolo[1,5-a]pirimidina farmacológicamente activos | |
| El-Hashash | Neural crest stem cells: a therapeutic hope machine for neural regeneration | |
| AR121666A1 (es) | DERIVADOS DE NAFTIRIDINA Y PIRIDO[3,4-C]PIRIDAZINA COMO MODULADORES DEL RECEPTOR GABAA a5 | |
| CO2023003078A2 (es) | Compuestos como moduladores de bis-fosfoglicerato mutasa para el tratamiento de la anemia de células falciforme | |
| CO2024002084A2 (es) | Compuestos n-acilidrazónicos inhibidores de nav 1.7 y/o nav 1.8, sus procesos de obtención, composiciones, usos, métodos de tratamiento de estos y kits | |
| AR127843A1 (es) | Composiciones y métodos para modular la expresión de apoc3 | |
| AR124316A1 (es) | Compuestos para tratar una enfermedad respiratoria | |
| Lopes et al. | Stem Cell Applications for Neurodegenerative Diseases | |
| Li et al. | Biological characteristics and clinical application of skin-derived precursor cells |